Hire Online Class Help
Free Assessments

NU576 Unit 5 Journal

NU576 Unit 5 Journal

NU576 Unit 5 Journal

Name

Purdue University Globle

NU576 NP II – Primary Care of Women’s Health

Prof. Name

Date

NU576 Unit 5 Journal

A 37-year-old female presenting with irregular, shortened menstrual cycles, fatigue, and thinning hair following the discontinuation of oral contraceptives is most likely experiencing Polycystic Ovary Syndrome (PCOS). Confirming this endocrine disorder requires a targeted diagnostic strategy—including total testosterone, thyroid-stimulating hormone (TSH), ferritin levels, and pelvic ultrasound imaging—to rule out secondary conditions such as endometriosis or uterine fibroids and to manage long-term metabolic risks.

Patient Presentation and Clinical History

Cindy Haas, a 37-year-old female high school teacher (Encounter #1524523, evaluated September 26, 2023), presented with a primary chief complaint of abnormal menstrual patterns lasting over a year. The patient noted that her menstrual cycles became noticeably lighter and shorter—lasting only two to three days and requiring just one to two pads daily—shortly after she discontinued hormonal birth control. She experiences mild lower abdominal cramping during menses but denies generalized pelvic pain, nausea, bowel changes, or urinary distress. Previous self-management strategies, including daily over-the-counter prenatal vitamins and acupuncture treatments, yielded no noticeable improvement.

The patient’s past medical history is free of chronic illness, major trauma, surgical interventions, or prior hospitalizations. She reports a known medication allergy to sulfa-based drugs, which causes a cutaneous rash, but reports no food or environmental intolerances. Her social history indicates a stable home life, married for 10 years, with no history of tobacco or recreational drug use and occasional alcohol consumption on weekends. Notably, her family history reveals a strong genetic predisposition to metabolic disease: her mother and sister have both been diagnosed with Type 2 diabetes mellitus, and her father has systemic hypertension.

During the systemic review, the patient denied weight fluctuations, fever, chest pain, dyspnea, or mood disturbances. However, she highlighted persistent fatigue, dry skin, and mild hair thinning.

Physical Examination Findings

Physical assessment revealed a well-nourished, alert, and cooperative female in no acute distress. Vital signs demonstrated hemodynamic stability: blood pressure was 120/70 mmHg, heart rate was 68 beats per minute, respiratory rate was 20 breaths per minute, and body temperature was 37.1°C. The patient weighs 170 lbs at a height of 5 feet 5 inches (Body Mass Index: 28.3 kg/m²).

Targeted organ system examinations yielded largely unremarkable findings:

  • Dermatologic: Skin was dry but intact, without active lesions, petechiae, or ecchymosis.

  • HEENT & Neurological: Cranial nerves were intact, pupils were equal, round, and reactive to light and accommodation (PERRLA), and the oral mucosa was moist. Speech was clear, and gait was steady.

  • Cardiopulmonary: Regular S1 and S2 heart sounds without murmurs; breath sounds were clear to auscultation bilaterally.

  • Abdominal: Soft, non-tender, non-distended, with active bowel sounds across all four quadrants and no organomegaly.

  • Gynecological: External genitalia appeared normal without lesions. Speculum examination revealed a healthy cervix free of discharge or cervical motion tenderness, and bimanual examination confirmed an anteverted, non-tender uterus with normal rectal tone. A screening Papanicolaou (Pap) test was successfully performed.

Diagnostic Evaluation and Laboratory Workup

To evaluate abnormal uterine bleeding and distinguish endocrine causes from structural abnormalities, a comprehensive laboratory panel is indicated.

Recommended Laboratory Tests

  • Total Testosterone: Evaluates hyperandrogenism, a hallmark clinical marker of PCOS.

  • Thyroid-Stimulating Hormone (TSH): Rules out underlying hypothyroidism or hyperthyroidism causing menstrual irregularity.

  • Serum Prolactin: Evaluates pituitary gland function to exclude hyperprolactinemia.

  • Complete Blood Count (CBC) & Serum Ferritin: Assesses overall hematologic status and checks for microcytic anemia or depleted iron stores.

  • Comprehensive Metabolic Panel (CMP): Evaluates baseline renal function, liver enzymes, and fasting blood glucose.

  • Qualitative Serum Pregnancy Test (Beta-hCG): Conclusively excludes pregnancy-related complications such as ectopic pregnancy or early spontaneous abortion.

Assessment and Differential Diagnosis

Primary Diagnosis: Polycystic Ovary Syndrome (PCOS)

PCOS represents the primary suspected diagnosis. The onset of oligomenorrhea following oral contraceptive cessation, combined with clinical signs of hyperandrogenism (hair thinning), systemic fatigue, and a strong familial background of Type 2 diabetes, aligns closely with Rotterdam diagnostic criteria for PCOS. This condition involves abnormal luteinizing hormone dynamics and elevated androgen production, leading to ovulatory disruption, subfertility, and long-term insulin resistance.

Differential Diagnosis: Endometriosis

Endometriosis involves ectopic endometrial tissue implantation outside the uterine cavity. While it frequently presents with cyclical lower abdominal cramping and bleeding irregularities, the patient lacks severe dysmenorrhea, dyspareunia, or chronic pelvic pain, making it a secondary consideration.

Differential Diagnosis: Uterine Fibroids

Uterine fibroids (leiomyomas) are benign smooth muscle tumors of the myometrium that frequently cause heavy menstrual bleeding, pelvic pressure, and structural displacement. Given that this patient experiences unusually light flow rather than menorrhagia, fibroids are less likely but require structural exclusion.

Evidence-Based Management Plan

Pharmacologic Interventions

First-line pharmacological management focuses on restoring hormonal regulation. Re-initiating a combination oral contraceptive pill (COCP) for a minimum of three months is recommended to regulate cyclic endometrial shedding and reduce ovarian androgen synthesis. For patients with persistent cutaneous symptoms or hyperandrogenism, anti-androgen therapy (such as spironolactone) may be considered following laboratory confirmation.

Lifestyle and Metabolic Modifications

Given the patient’s elevated BMI and significant family history of diabetes, non-pharmacologic lifestyle counseling is vital:

  • Adopting a low-glycemic, anti-inflammatory dietary pattern to optimize insulin sensitivity.

  • Engaging in at least 150 minutes of moderate-intensity aerobic exercise per week.

  • Implementing regular blood glucose and HbA1c monitoring to detect metabolic dysfunction early.

Pelvic Imaging and Diagnostic Procedures

A high-resolution transvaginal pelvic ultrasound should be ordered to evaluate ovarian morphology ( assessing for “string-of-pearls” polycystic appearance), measure endometrial thickness, and definitively rule out uterine fibroids or structural pathology.

Patient Education, Preventive Care, and Referral

Patient education must address both short-term cycle regulation and long-term wellness. The patient should be counseled on the association between PCOS, cardiometabolic disease, and ovulatory dysfunction.

Cultural considerations and personal values regarding contraception should frame every treatment conversation, utilizing shared decision-making to align therapeutic strategies with her future family planning goals. Routine health maintenance—including age-appropriate breast health awareness and tracking Pap test cytology results—remains essential.

A formal referral to an Obstetrics and Gynecology (OB/GYN) specialist is recommended for advanced endocrine management. A follow-up clinical evaluation is scheduled in 12 weeks to review diagnostic imaging, evaluate hormone panels, and adjust the therapeutic plan based on symptom resolution.

References

Categories

BSN
NURS-FPX4000
NURS-FPX4005
NURS-FPX4015
NURS-FPX4025
NURS-FPX4035
NURS-FPX4045
NURS-FPX4055
NURS-FPX4065
NURS-FPX4905